Advertisement
Home »

Cytokine levels in patients with non-M3 myeloid leukemia are key indicators of how well the disease responds to chemotherapy.

Nov 06, 2023

ABOUT THE EXPERTS

  • Rui Hu

    Department of Hematology, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.

    Yunnan Province Clinical Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Blood Disease Hospital, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Province Clinical Research Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Xiaosui Ling

    Department of Hematology, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.

    Yunnan Province Clinical Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Blood Disease Hospital, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Province Clinical Research Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Tonghua Yang

    Department of Hematology, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.

    Yunnan Province Clinical Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Blood Disease Hospital, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Province Clinical Research Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Jinping Zhang

    Department of Hematology, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.

    Yunnan Province Clinical Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Blood Disease Hospital, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Province Clinical Research Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Xuezhong Gu

    Department of Hematology, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.

    Yunnan Province Clinical Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Blood Disease Hospital, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Province Clinical Research Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Fan Li

    Department of Hematology, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.

    Yunnan Province Clinical Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Blood Disease Hospital, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Province Clinical Research Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Heng Chen

    The Second Clinical Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China.

    Yan Wen

    Department of Hematology, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China.

    Yunnan Province Clinical Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Blood Disease Hospital, The First People’s Hospital of Yunnan Province, Kunming, China.

    Yunnan Province Clinical Research Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China.

    Zengzheng Li

    Department of Hematology, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China. Lizengzheng@126.com.

    Yunnan Province Clinical Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China. Lizengzheng@126.com.

    Yunnan Blood Disease Hospital, The First People’s Hospital of Yunnan Province, Kunming, China. Lizengzheng@126.com.

    Yunnan Province Clinical Research Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China. Lizengzheng@126.com.

    Yunlian Zou

    Department of Hematology, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China. 853200844@qq.com.

    Yunnan Province Clinical Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China. 853200844@qq.com.

    Yunnan Blood Disease Hospital, The First People’s Hospital of Yunnan Province, Kunming, China. 853200844@qq.com.

    Yunnan Province Clinical Research Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China. 853200844@qq.com.

    Yunyun Du

    Department of Hematology, The First People’s Hospital of Yunnan Province, Affiliated Hospital of Kunming University of Science and Technology, Kunming, China. 173843716@qq.com.

    Yunnan Province Clinical Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China. 173843716@qq.com.

    Yunnan Blood Disease Hospital, The First People’s Hospital of Yunnan Province, Kunming, China. 173843716@qq.com.

    Yunnan Province Clinical Research Center for Hematologic Disease, The First People’s Hospital of Yunnan Province, Kunming, China. 173843716@qq.com.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement